Basic Information
LEXOTAN TABLET 3 mg
TABLET
Regulatory Information
SIN00382P
April 27, 1988
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 4, 2025
XN05BA08
Company Information
Active Ingredients
Strength: 3 mg
Detailed Information
Contraindications
**2.3 Contraindications** Lexotan is contraindicated in patients with: - known hypersensitivity to benzodiazepines or any of the excipients - severe respiratory insufficiency - severe hepatic impairment as benzodiazepines may precipitate hepatic encephalopathy - sleep apnea syndrome
Indication Information
**2.1 Therapeutic Indication(s)** Lexotan is indicated for anxiety, tension and other somatic or psychiatric complaints associated with the anxiety syndrome. It can also be used as an adjunct for treatment of anxiety or excitation associated with psychiatric disorders, such as mood disorders or schizophrenia. Benzodiazepines are only indicated when the disorder is severe, disabling or subjecting the individual to extreme distress.